155 related articles for article (PubMed ID: 38456232)
1. The Finnegan Score for Neonatal Opioid Withdrawal Revisited With Routine Electronic Data: Retrospective Study.
Rech T; Rubarth K; Bührer C; Balzer F; Dame C
JMIR Pediatr Parent; 2024 Feb; 7():e50575. PubMed ID: 38456232
[TBL] [Abstract][Full Text] [Related]
2. Integrated Review of the Assessment of Newborns With Neonatal Abstinence Syndrome.
Casavant SG; Meegan T; Fleming M; Hussain N; Gork S; Cong X
J Obstet Gynecol Neonatal Nurs; 2021 Sep; 50(5):539-548. PubMed ID: 34116058
[TBL] [Abstract][Full Text] [Related]
3. Neonatal Abstinence Signs during Treatment: Trajectory, Resurgence and Heterogeneity.
Miller JS; Bada HS; Westgate PM; Sithisarn T; Leggas M
Children (Basel); 2024 Feb; 11(2):. PubMed ID: 38397314
[TBL] [Abstract][Full Text] [Related]
4. Effect of a Neonatal Abstinence Syndrome Training Program on Nurses' Confidence and Ability to Use the Finnegan Scoring Tool.
Clark AF
Nurs Womens Health; 2019 Dec; 23(6):485-493. PubMed ID: 31676285
[TBL] [Abstract][Full Text] [Related]
5. Newborn Cry Acoustics in the Assessment of Neonatal Opioid Withdrawal Syndrome Using Machine Learning.
Manigault AW; Sheinkopf SJ; Silverman HF; Lester BM
JAMA Netw Open; 2022 Oct; 5(10):e2238783. PubMed ID: 36301544
[TBL] [Abstract][Full Text] [Related]
6. Physiologic Indirect Response Modeling to Describe Buprenorphine Pharmacodynamics in Newborns Treated for Neonatal Opioid Withdrawal Syndrome.
Mizuno T; McPhail BT; Kamatkar S; Wexelblatt S; Ward L; Christians U; Akinbi HT; Vinks AA
Clin Pharmacokinet; 2021 Feb; 60(2):249-259. PubMed ID: 32939690
[TBL] [Abstract][Full Text] [Related]
7. A Quality Improvement Initiative to Increase Scoring Consistency and Accuracy of the Finnegan Tool: Challenges in Obtaining Reliable Assessments of Drug Withdrawal in Neonatal Abstinence Syndrome.
Timpson W; Killoran C; Maranda L; Picarillo A; Bloch-Salisbury E
Adv Neonatal Care; 2018 Feb; 18(1):70-78. PubMed ID: 29045256
[TBL] [Abstract][Full Text] [Related]
8. Association of a Simplified Finnegan Neonatal Abstinence Scoring Tool With the Need for Pharmacologic Treatment for Neonatal Abstinence Syndrome.
Devlin LA; Breeze JL; Terrin N; Gomez Pomar E; Bada H; Finnegan LP; O'Grady KE; Jones HE; Lester B; Davis JM
JAMA Netw Open; 2020 Apr; 3(4):e202275. PubMed ID: 32267513
[TBL] [Abstract][Full Text] [Related]
9. Pilot Study Comparing Modified Finnegan Scoring Versus Adjusted Scoring System for Infants With Iatrogenic Opioid Abstinence Syndrome After Cardiothoracic Surgery.
Capino AC; Johnson PN; Williams PK; Anderson MP; Bedwell S; Miller JL
J Pediatr Pharmacol Ther; 2019; 24(2):148-155. PubMed ID: 31019408
[TBL] [Abstract][Full Text] [Related]
10. Early Prediction Tool to Identify the Need for Pharmacotherapy in Infants at Risk of Neonatal Abstinence Syndrome.
Isemann BT; Stoeckle EC; Taleghani AA; Mueller EW
Pharmacotherapy; 2017 Jul; 37(7):840-848. PubMed ID: 28500629
[TBL] [Abstract][Full Text] [Related]
11. Differences in the profile of neonatal abstinence syndrome signs in methadone- versus buprenorphine-exposed neonates.
Gaalema DE; Scott TL; Heil SH; Coyle MG; Kaltenbach K; Badger GJ; Arria AM; Stine SM; Martin PR; Jones HE
Addiction; 2012 Nov; 107 Suppl 1(0 1):53-62. PubMed ID: 23106927
[TBL] [Abstract][Full Text] [Related]
12. Simplification of the Finnegan Neonatal Abstinence Scoring System: retrospective study of two institutions in the USA.
Gomez Pomar E; Finnegan LP; Devlin L; Bada H; Concina VA; Ibonia KT; Westgate PM
BMJ Open; 2017 Sep; 7(9):e016176. PubMed ID: 28963285
[TBL] [Abstract][Full Text] [Related]
13. Neonatal abstinence syndrome.
Kocherlakota P
Pediatrics; 2014 Aug; 134(2):e547-61. PubMed ID: 25070299
[TBL] [Abstract][Full Text] [Related]
14. Evaluation and analysis of the Modified Finnegan Scoring System for assessment of neonatal abstinence syndrome.
Baloch RQ; Pinto JM; Greenberg P; Kuo YH; Siu A
J Opioid Manag; 2020; 16(3):189-196. PubMed ID: 32421839
[TBL] [Abstract][Full Text] [Related]
15. Improving the Assessment of Neonatal Abstinence Syndrome (NAS).
Chin Foo CA; Dansereau LM; Hawes K; Oliveira EL; Lester BM
Children (Basel); 2021 Aug; 8(8):. PubMed ID: 34438576
[TBL] [Abstract][Full Text] [Related]
16. Sedatives for opiate withdrawal in newborn infants.
Osborn DA; Jeffery HE; Cole MJ
Cochrane Database Syst Rev; 2005 Jul; (3):CD002053. PubMed ID: 16034870
[TBL] [Abstract][Full Text] [Related]
17. Delivery timing for the opioid-exposed infant.
Sanusi A; Gray M; Xue Y; Mohr S; Curtis P; Dismukes J; Gentle S; Szychowski JM; Brocato B; Casey B; Harper L; Sinkey R
Am J Obstet Gynecol MFM; 2022 Nov; 4(6):100719. PubMed ID: 35977700
[TBL] [Abstract][Full Text] [Related]
18. Impact of Parental Presence at Infants' Bedside on Neonatal Abstinence Syndrome.
Howard MB; Schiff DM; Penwill N; Si W; Rai A; Wolfgang T; Moses JM; Wachman EM
Hosp Pediatr; 2017 Feb; 7(2):63-69. PubMed ID: 28137920
[TBL] [Abstract][Full Text] [Related]
19. Opioid treatment for opioid withdrawal in newborn infants.
Zankl A; Martin J; Davey JG; Osborn DA
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD002059. PubMed ID: 34231914
[TBL] [Abstract][Full Text] [Related]
20. The economic burden of neonatal abstinence syndrome in the United States.
Corr TE; Hollenbeak CS
Addiction; 2017 Sep; 112(9):1590-1599. PubMed ID: 28612362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
